1-(azetidin-1-yl)-2-tert-butyl-4-[5-cyclopropyl-4-[(2S)-1,1,1-trifluoropropan-2-yl]oxy-2-pyridinyl]butane-1,4-dione
C22H29F3N2O3 — CID 157413919
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(azetidin-1-yl)-2-tert-butyl-4-[5-cyclopropyl-4-[(2S)-1,1,1-trifluoropropan-2-yl]oxy-2-pyridinyl]butane-1,4-dione
1-(azetidin-1-yl)-2-tert-butyl-4-[5-cyclopropyl-4-[(2S)-1,1,1-trifluoropropan-2-yl]oxy-2-pyridinyl]butane-1,4-dione (PubChem CID 157413919) has the molecular formula C22H29F3N2O3 and a molecular weight of 426.48 g/mol. Its IUPAC name is 1-(azetidin-1-yl)-2-tert-butyl-4-[5-cyclopropyl-4-[(2S)-1,1,1-trifluoropropan-2-yl]oxy-2-pyridinyl]butane-1,4-dione.
Molecular Properties
| Compound Name | 1-(azetidin-1-yl)-2-tert-butyl-4-[5-cyclopropyl-4-[(2S)-1,1,1-trifluoropropan-2-yl]oxy-2-pyridinyl]butane-1,4-dione |
|---|---|
| PubChem CID | 157413919 |
| Molecular Formula | C22H29F3N2O3 |
| Molecular Weight | 426.48 g/mol |
| Exact Mass | 426.21 |
| IUPAC Name | 1-(azetidin-1-yl)-2-tert-butyl-4-[5-cyclopropyl-4-[(2S)-1,1,1-trifluoropropan-2-yl]oxy-2-pyridinyl]butane-1,4-dione |
| SMILES | C[C@H](Oc1cc(C(=O)CC(C(=O)N2CCC2)C(C)(C)C)ncc1C1CC1)C(F)(F)F |
| InChI | InChI=1S/C22H29F3N2O3/c1-13(22(23,24)25)30-19-11-17(26-12-15(19)14-6-7-14)18(28)10-16(21(2,3)4)20(29)27-8-5-9-27/h11-14,16H,5-10H2,1-4H3/t13-,16?/m0/s1 |
| InChIKey | BOPOKZREZIQYBV-KNVGNIICSA-N |
| XLogP | 4.76 |
| TPSA | 59.50 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 426.48 |
| LogP ≤ 5 | 4.76 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157413919 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.